Opportunities for improving managed care for individuals with dementia: Part 1 - The issues

Howard Fillit, David Knopman, Jeffrey Cummings, Frank Appel

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Abstract

In this first part of a two-part article, we review the prevalence of, costs associated with, and treatments for Alzheimer's disease and related dementias, a leading cause of disability in the elderly. New, innovative, and costly drugs to combat dementia are being introduced, causing pharmacy costs to rise. These new drugs, however, may reduce overall medical costs and improve the quality of life of patients with dementia and their caregivers. Issues of cost, excessive service utilization, and quality of life will have significant impact on managed care organizations in the near future as the rapidly aging population experiences significant disability and illness related to dementia. In the second part of this article, we describe the framework for a disease management program for patients with dementia, similar to programs in existence for diabetes and other chronic diseases, that could enable managed care organizations to effectively care for these patients.

Original languageEnglish (US)
Pages (from-to)309-315
Number of pages7
JournalAmerican Journal of Managed Care
Volume5
Issue number3
StatePublished - Mar 1 1999

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Opportunities for improving managed care for individuals with dementia: Part 1 - The issues'. Together they form a unique fingerprint.

Cite this